Full-Time

Senior Medical Director

Clinical Development, Genetics Medicines, CV/Metabolism

Confirmed live in the last 24 hours

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

10,001+ employees

Develops medicines for serious diseases

Biotechnology
Healthcare

Compensation Overview

$328.4k - $444.2kAnnually

Senior

Cambridge, MA, USA + 1 more

More locations: Tarrytown, NY, USA

The job is not remote and requires in-office presence.

Category
Genomics
Physicians & Surgeons
Medical, Clinical & Veterinary
Biology & Biotech

You match the following Regeneron Pharmaceuticals's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • An M.D. or D.O. or equivalent medical degree (MD/PhD preferred) and relevant residency/fellowship training is required with a strong preference for Cardiovascular or Endocrinology clinical training/background.
  • A minimum of 4 years of clinical development experience in an industry setting is required, with a track record of meaningful contributions to and accomplishment in conducting clinical trials (e.g., planning, implementing, reporting and publishing) and/or leading clinical programs.
  • Solid knowledge of compliance and global regulatory requirements (ICH) for development of pharmaceutical candidate products is required.
  • Strong understanding of operational aspects of all phases of clinical trial conduct (start-up, conduct, close-out).
Responsibilities
  • Leads clinical program(s) and acts as a clinical expert and leader in interactions with external stakeholders (e.g., regulatory authorities, key opinion leaders, advisory boards), internal stakeholders (e.g., Research, Regeneron Genetics Center, Regulatory Affairs, Global Clinical Development, Precision Medicine, HEOR), and internal decision committees.
  • Develops unique and innovative clinical strategies to significantly shorten the development cycle in the face of an evolving regulatory landscape. Designs and develops efficient and innovative Phase 1, 2, and 3 programs.
  • Works closely with the research and discovery teams to provide input on the next generation of targets in Cardiovascular/Metabolic diseases.
  • Ensures safety of the drug, including the safety aspects of patients in clinical studies and signal detection from post-marketing surveillance, with the support from Global Patient Safety.
  • Ensures quality of all clinical documents (e.g., investigators’ brochure, protocol, study report, clinical components of regulatory submissions, safety related documents).
  • Develops written responses to regulatory agency questions and prepares regulatory submission documents.
  • Has strong consensus-building and stakeholder management skills with a strong ability to collaborate with multi-disciplinary teams towards sound decision-making.
Desired Qualifications
  • Direct clinical development experience in CV/Metabolic therapeutic area is preferred.
  • Research experience in an academic setting preferred.
Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

View

Regeneron Pharmaceuticals develops medicines aimed at treating serious diseases such as cancer, eye diseases, and allergic conditions. The company uses its own technologies and extensive research to create new therapies, often collaborating with academic institutions and other pharmaceutical companies to enhance its development efforts. Unlike many competitors, Regeneron focuses on both research and commercialization, generating revenue through the sale of its approved medicines and licensing its technologies. The goal of Regeneron is to improve patient outcomes by providing effective treatments and ensuring that its products meet high safety and efficacy standards.

Company Stage

IPO

Total Funding

$684M

Headquarters

Town of Greenburgh, New York

Founded

1988

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing antibody therapy market offers expansion opportunities for Regeneron.
  • Investment in Truveta's genome project accelerates personalized medicine initiatives.
  • Acquisition of Oxular strengthens Regeneron's position in retinal disorder treatments.

What critics are saying

  • Class action lawsuit may lead to financial liabilities and reputational damage.
  • Truveta investment might not yield expected returns, posing financial risk.
  • Integration challenges with Oxular could affect operational efficiency.

What makes Regeneron Pharmaceuticals unique

  • Regeneron leverages proprietary technologies for innovative therapies in serious diseases.
  • Strategic collaborations enhance Regeneron's research and development capabilities.
  • Regeneron's focus on eye diseases and monoclonal antibodies sets it apart.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Wellness Program

Paid Vacation

Equity Awards

Annual Bonuses

Flexible Work Hours